ExPERT STx®
The industry’s leading scalable electroporation technology for high-yield, transient expression of complex proteins, vaccines and biologics
Rapidly transfect up to 20 billion cells
Proprietary Flow Electroporation® technology
Closed, cGMP-compliant system, 21 CFR part 11 compliant, ISO-certified and CE-marked
Improved yields, at scale, can decrease development timelines and, paired with flexible media strategies, deliver significant cost savings
Faster production of stable clones
Ideal for large-scale cell therapy optimization, training, process development and feasibility studies from early product development to pre-IND validation studies
Product features
Integrated touch screen - Easily operate with just the touch of a finger.
Enhanced software user interface - Save time with updated software, providing additional functionality and intuitive use.
Reduced footprint - Bench-scale, modular equipment saves valuable lab space.
Network capable - Generate and save run reports automatically onto a shared local drive.
LED status indicators - Quickly visualize instrument and run status with six colorful and clearly defined status modes.
Retractable bag hooks - Utilize convenient hooks for large volume processing and then fold them away when you don’t need them.
Elegant design - Enjoy a modern, sleek appearance that fits seamlessly into any high-tech lab space.
Choosing MaxCyte® gives you more than just an instrument — you get the best cell engineering platform and a partner with the knowledge to support you to reach your research and manufacturing goals
Supporting products
Compatible consumables & accessories
Research applications
Learn how scientists are using the STx™
This content was adapted from Byrne et al. 2018 under the Creative Commons license Attribution 4.0 International (CC BY 4.0) .
CRISPR-Cas9 gene editing for the creation of an MGAT1-deficient CHO cell line to control HIV-1 vaccine glycosylation
Gene editing of a suspension-adapted CHO cell line to enable production of suitably glycosylated HIV-1 proteins for vaccine development